Nahdi Medical Company

TADAWUL:4164.SR

132.8 (SAR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SAR.

2023202220212020201920182017
Operating Activities:
Net Income 944.246937.925857.267849.116692.002610.653721.237
Depreciation & Amortization 618.081596.643571.5518.126495.326143.042136.529
Deferred Income Tax 0000000
Stock Based Compensation 0000000
Change In Working Capital -155.03152.491-13.402-37.799-31.19496.85813.367
Accounts Receivables -38.1566.892-47.65258.642-58.2281.964-15.524
Inventory -214.621-127.01385.851-189.426-33.13149.618-258.028
Accounts Payables 257.142153.17143.738-70.24784.4715.664245.459
Other Working Capital -159.39519.441-95.339163.232-24.30739.61241.46
Other Non Cash Items -38.56880.812-81.3951,493.6891,189.471358.257340.723
Operating Cash Flow 1,368.7281,667.8711,333.971,585.8481,348.066979.972910.705
Investing Activities:
Investments In Property Plant And Equipment -384.511-275.233-306.467-319.8-234.418-183.016-177.961
Acquisitions Net 0.2540.1037.10213.8226.18400
Purchases Of Investments 000-192.702-2.472-200.3590
Sales Maturities Of Investments 000202.83212.73200
Other Investing Activites -30.395-24.863-16.79192.702-12.732-220.878-10.234
Investing Cash Flow -384.257-275.13-299.365-103.146-230.706-383.375-177.961
Financing Activities:
Debt Repayment -435.674-416.964-382.068-311.526-415.080-200
Common Stock Issued 0000000
Common Stock Repurchased 0000000
Dividends Paid -715-300.3-1,260-535-500-550-602.6
Other Financing Activities -435.674-416.964-382.068-311.526-415.080-200
Financing Cash Flow -1,150.674-717.264-1,642.068-846.526-915.08-550-802.6
Other Information:
Effect Of Forex Changes On Cash -0.448-0.21-0.0240000
Net Change In Cash -166.65675.268-607.485636.176202.2848.838-69.856
Cash At End Of Period 909.6621,076.312401.0441,008.53372.354170.073121.235